Magnus A B Axelsson

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

End Stage Renal Disease

Oxide Nanoparticles

High Resolution Mass Spectrometry

Top Venues

British journal of clinical pharmacology

Basic & clinical pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Magnus A B Axelsson, Carina Tukukino, Naldy Parodi López, Susanna M Wallerstedt
Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low-dose acetylsalicylic acid (ASA) compared with SSRI or low-dose ASA alone-A systematic review and meta-analysis. British journal of clinical pharmacology (2024)
Magnus A B Axelsson, Carina Tukukino, Naldy Parodi López, Susanna M Wallerstedt
Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low-dose acetylsalicylic acid (ASA) compared with SSRI or low-dose ASA alone-A systematic review and meta-analysis. British journal of clinical pharmacology 90 (4) (2024)
Magnus A B Axelsson, Carina Tukukino, Naldy Parodi López, Susanna M Wallerstedt
Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low-dose acetylsalicylic acid (ASA) compared with SSRI or low-dose ASA alone-A systematic review and meta-analysis. British journal of clinical pharmacology 90 (4) (2024)
Magnus A B Axelsson, Carina Tukukino, Naldy Parodi López, Susanna M Wallerstedt
Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low-dose acetylsalicylic acid (ASA) compared with SSRI or low-dose ASA alone-A systematic review and meta-analysis. British journal of clinical pharmacology 90 (4) (2024)
Magnus A B Axelsson, Hanna Lövgren, Robert Kronstrand, Henrik Green, Moa Andresen Bergström
Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis. Basic & clinical pharmacology & toxicology 131 (5) (2022)